ATE461702T1 - Krebsmittel - Google Patents

Krebsmittel

Info

Publication number
ATE461702T1
ATE461702T1 AT06711726T AT06711726T ATE461702T1 AT E461702 T1 ATE461702 T1 AT E461702T1 AT 06711726 T AT06711726 T AT 06711726T AT 06711726 T AT06711726 T AT 06711726T AT E461702 T1 ATE461702 T1 AT E461702T1
Authority
AT
Austria
Prior art keywords
sup
sub
cancer
antitumor agent
tumor
Prior art date
Application number
AT06711726T
Other languages
English (en)
Inventor
Koji Yoshinaga
Daisuke Kawasaki
Yutaka Emori
Original Assignee
Zeria Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeria Pharm Co Ltd filed Critical Zeria Pharm Co Ltd
Application granted granted Critical
Publication of ATE461702T1 publication Critical patent/ATE461702T1/de

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06711726T 2005-01-19 2006-01-16 Krebsmittel ATE461702T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005011158 2005-01-19
JP2006000445 2006-01-16

Publications (1)

Publication Number Publication Date
ATE461702T1 true ATE461702T1 (de) 2010-04-15

Family

ID=40290725

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06711726T ATE461702T1 (de) 2005-01-19 2006-01-16 Krebsmittel

Country Status (2)

Country Link
AT (1) ATE461702T1 (de)
MX (1) MX2007008753A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022162693A1 (en) * 2021-01-27 2022-08-04 Vidya Desai Benzodiazepine compounds having anti-cancer activity and a process for preparation thereof

Also Published As

Publication number Publication date
MX2007008753A (es) 2007-09-26

Similar Documents

Publication Publication Date Title
HRP20090281T1 (hr) 1,2,3,4-tetrasubstituirani indol za liječenje respiratornih bolesti
MXPA05009985A (es) Ligandos de receptores de canabinoides.
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
PH12012501351A1 (en) Synthesis of eporthilones, intermediates thereto, analogues and uses thereof
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
MX2010004232A (es) Compuesto de indolina de pirimidilo.
WO2004018475A3 (en) Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
EP1839662A4 (de) Krebsmittel
IL174665A0 (en) Heterocyclic compounds which act as p-glycoprotein inhibitors and pharmaceutical compositions containing the same
EA200501703A1 (ru) Применение производных азетидинкарбоксамида в терапии
TW200630364A (en) 2-amido-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
PL370981A1 (en) Substituted diketopiperazines as oxytocin antagonists
MXPA05005790A (es) Aminoalcoxiindoles como ligandos del receptor 5-ht6 para el tratamiento de enfermedades del sistema nervioso central.
EA200701780A1 (ru) Противоопухолевое средство
SG145570A1 (en) 4-æ7-halo-2-quino(xa-)linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
ATE424200T1 (de) Solubilisierte topoisomerase-gift-mittel
ATE390923T1 (de) Topoisomerase-giftmittel
IL160082A0 (en) Quinoline derivatives and use thereof as antitumor agents
MXPA05011521A (es) Derivado de 4,4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o una sal del mismo.
TNSN08093A1 (en) Quinoline derivatives and use as antitumor agents
TW200509915A (en) Novel oxazoles, their manufacture and use as pharmaceutical agents
DK1684763T3 (da) 6-Aryl-7-halogen-imidazo(1,2-a)pyrimidiner som anticancermiddel
ATE301997T1 (de) Antivirale therapie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1839662

Country of ref document: EP